DOUBLETS AND TRIPLETS : NEW DRUG COMBINATIONS IN THE PALLIATIVE CARE OF NSCLC

Chemotherapy has been shown to prolong survival in patients with stage IV non-small-cell lung cancer (NSCLC). However, traditional cisplatin (Platinol)-containing regimens are associated with significant toxicity.